COPD / Cognitive Function / Osteoarthritis and OSA

The Cognitive Cost of COPD and OSA

A recent study Hansen et al explored the impact of OSA on cognitive function in patients with severe COPD. Conducted with 80 COPD patients, the study found a high prevalence of OSA (63%), with 23% experiencing moderate to severe OSA. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA), reaction time tests, and driving simulations.

There was no significant overall difference in cognitive impairment between patients with and without OSA. Those with moderate/severe OSA demonstrated poorer attention and reaction times compared to patients with mild OSA. This highlights that the severity of OSA is a key factor influencing cognitive decline in COPD patients.

Patients treated for OSA with CPAP or nocturnal oxygen therapy for at least four months showed slight improvement in short-term memory, suggesting a modest cognitive benefit from treatment. However, no significant changes were seen in overall cognitive function.

Key Message:

The study underscores the importance of screening for OSA in COPD patients, particularly those with severe disease. Moderate to severe OSA may exacerbate cognitive impairment, impacting quality of life and daily function. Early diagnosis and effective management of OSA through CPAP therapy could help mitigate its cognitive impact.

OSA and Osteoarthritis – A Weighty Connection

A new genetic study by Xu et al has ripped apart the assumed genetic link between OSA and osteoarthritis, laying bare the real culprit: obesity. For years, observational studies have hinted at a connection between the two chronic conditions, but this research, using advanced Mendelian randomisation, proves that the relationship is not causal.

Here’s the hard truth: when researchers adjusted for BMI, the previously significant association between OSA and OA vanished into thin air. Whether it’s knee OA, hip OA, or both, it’s not OSA itself driving the risk—it’s the extra weight acting as a shared risk factor.

Patients with OSA and OA often find themselves caught in a vicious cycle. Poor sleep exacerbates fatigue, reducing physical activity and contributing to weight gain. In turn, higher BMI worsens OA symptoms and increases the risk of OSA severity. Tackling obesity, therefore, becomes the linchpin for addressing both conditions.

Key message:

Weight loss must be part of the frontline intervention for managing these conditions. However, it’s not as simple as “eat less, move more”—OSA itself makes weight management a tougher battle by disrupting sleep, increasing fatigue, and driving hormonal changes that promote weight gain. This vicious cycle means clinicians must adopt a holistic, evidence-based approach and effective OSA treatment to improve sleep quality and help patients achieve meaningful weight loss. Breaking this cycle can improve outcomes in both OSA and OA.